Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/1337

TDMS Study 05049-02 Pathology Tables


                                     INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)
                                                             DICHLORVOS


NTP Experiment-Test: 05049-02                                                                                     Report: PEIRPT03
Study Type: CHRONIC                                                                                               Date: 09/07/94
Route: GAVAGE                                                                                                     Time: 05:32:15




       Facility:  Southern Research Institute

       Chemical CAS #:  62-73-7

       Lock Date:  None

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All
































a  Number of animals examined microscopically at site and number of animals with lesion

                                                             Page   1

NTP Experiment-Test: 05049-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             DICHLORVOS                                        Date: 09/07/94  
Route: GAVAGE                                                                                                     Time: 05:32:15  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        VEHICLE      20.0         40.0                                                   
                                                   CONTROL      MG/KG        MG/KG                                                  
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          50           50           50                                                  
  Early Deaths                                                                                                                      
    Moribund                                          15            5            9                                                  
    Accident                                           6            5            2                                                  
    Dead                                               3           11            5                                                  
  Survivors                                                                                                                         
    Terminal Sacrifice                                25           29           34                                                  
    Dead                                               1                                                                            
  Animals Examined Microscopically                    50           50           50                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (49)         (48)         (50)                                                
      Diverticulum                                     1 (2%)                                                                       
      Necrosis                                         1 (2%)                                                                       
      Muscularis, Inflammation, Chronic                             1 (2%)                                                          
   Gallbladder                                        (33)         (41)         (45)                                                
      Cyst                                                                       1 (2%)                                             
      Infiltration Cellular, Lymphocyte                             1 (2%)       1 (2%)                                             
   Intestine Large                                    (49)         (50)         (50)                                                
      Cecum, Hyperplasia, Lymphoid                     2 (4%)                                                                       
      Cecum, Mucosa, Necrosis                                                    1 (2%)                                             
   Intestine Small                                    (46)         (49)         (48)                                                
      Duodenum, Amyloid Deposition                                               1 (2%)                                             
      Duodenum, Hyperplasia, Re Cell                   1 (2%)                                                                       
      Ileum, Amyloid Deposition                                                  3 (6%)                                             
      Jejunum, Amyloid Deposition                                                2 (4%)                                             
      Jejunum, Fibrosis                                             1 (2%)                                                          
      Jejunum, Inflammation, Suppurative                            1 (2%)                                                          
      Jejunum, Necrosis                                             1 (2%)                                                          
      Jejunum, Peyer's Patch, Hyperplasia, Lymphoid                 1 (2%)       3 (6%)                                             
      Jejunum, Peyer's Patch, Hyperplasia,                                                                                          
          Mononuclear Cell                             1 (2%)                                                                       
      Mucosa, Ileum, Dysplasia                         1 (2%)                                                                       
      Submucosa, Ileum, Infiltration Cellular,                                                                                      
           Plasma Cell                                 1 (2%)                                                                       
   Liver                                              (50)         (50)         (50)                                                
      Angiectasis                                                                1 (2%)                                             
      Clear Cell Focus                                                           1 (2%)                                             
      Fibrosis                                                                   1 (2%)                                             
      Hematopoietic Cell Proliferation                 8 (16%)      5 (10%)      3 (6%)                                             
      Infiltration Cellular, Mononuclear Cell                                    1 (2%)                                             
      Inflammation, Chronic                           15 (30%)      5 (10%)     13 (26%)                                            
      Inflammation, Chronic Active                     2 (4%)       3 (6%)       1 (2%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    2                                                              
NTP Experiment-Test: 05049-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             DICHLORVOS                                        Date: 09/07/94  
Route: GAVAGE                                                                                                     Time: 05:32:15  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        VEHICLE      20.0         40.0                                                   
                                                   CONTROL      MG/KG        MG/KG                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Inflammation, Suppurative                                     1 (2%)                                                          
      Bile Duct, Cyst                                  1 (2%)                    1 (2%)                                             
      Hepatocyte, Cytoplasmic Alteration               1 (2%)                    1 (2%)                                             
      Hepatocyte, Karyomegaly                          1 (2%)       1 (2%)       1 (2%)                                             
      Hepatocyte, Necrosis                             5 (10%)      8 (16%)      5 (10%)                                            
      Hepatocyte, Vacuolization Cytoplasmic            4 (8%)       2 (4%)       4 (8%)                                             
      Kupffer Cell, Hyperplasia                        3 (6%)       5 (10%)      4 (8%)                                             
      Kupffer Cell, Pigmentation                       3 (6%)                                                                       
   Mesentery                                          (13)         (10)         (7)                                                 
      Inflammation, Chronic                            1 (8%)       2 (20%)                                                         
      Inflammation, Chronic Active                                  1 (10%)                                                         
      Inflammation, Suppurative                        5 (38%)      2 (20%)      1 (14%)                                            
      Artery, Hypertrophy                              1 (8%)                                                                       
      Artery, Inflammation, Chronic                    2 (15%)                                                                      
      Fat, Inflammation, Chronic Active                                          1 (14%)                                            
      Fat, Mineralization                                                        3 (43%)                                            
      Fat, Necrosis, Focal                             1 (8%)       1 (10%)      4 (57%)                                            
   Pancreas                                           (47)         (49)         (49)                                                
      Atrophy                                          2 (4%)                    1 (2%)                                             
      Cytoplasmic Alteration                           1 (2%)                    1 (2%)                                             
      Hyperplasia, Focal                               1 (2%)                                                                       
      Infarct                                          1 (2%)                                                                       
      Inflammation, Chronic                            4 (9%)       3 (6%)       1 (2%)                                             
      Acinus, Vacuolization Cytoplasmic                                          1 (2%)                                             
   Salivary Glands                                    (49)         (50)         (50)                                                
      Inflammation, Chronic                            5 (10%)      6 (12%)      7 (14%)                                            
      Inflammation, Suppurative                                                  1 (2%)                                             
   Stomach                                            (49)         (49)         (50)                                                
      Forestomach, Cyst                                1 (2%)                                                                       
      Forestomach, Diverticulum                        1 (2%)                    1 (2%)                                             
      Forestomach, Erosion                             1 (2%)                                                                       
      Forestomach, Foreign Body                                                  1 (2%)                                             
      Forestomach, Hyperplasia, Focal                  6 (12%)      6 (12%)      5 (10%)                                            
      Forestomach, Inflammation, Acute                 1 (2%)                                                                       
      Forestomach, Inflammation, Chronic               1 (2%)                                                                       
      Forestomach, Inflammation, Chronic Active                     2 (4%)       2 (4%)                                             
      Forestomach, Inflammation, Suppurative                                     2 (4%)                                             
      Forestomach, Mineralization                                   1 (2%)                                                          
      Forestomach, Mucosa, Hyperplasia, Focal                       1 (2%)                                                          
      Glandular, Atrophy                                                         1 (2%)                                             
      Glandular, Cyst                                               2 (4%)                                                          
      Glandular, Edema                                 1 (2%)                                                                       
      Glandular, Erosion                               1 (2%)                                                                       
      Glandular, Hemorrhage                                         1 (2%)                                                          
      Glandular, Inflammation, Chronic                 1 (2%)                                                                       
      Glandular, Inflammation, Suppurative             3 (6%)                    1 (2%)                                             
      Glandular, Metaplasia, Squamous                               1 (2%)       1 (2%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    3                                                              
NTP Experiment-Test: 05049-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             DICHLORVOS                                        Date: 09/07/94  
Route: GAVAGE                                                                                                     Time: 05:32:15  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        VEHICLE      20.0         40.0                                                   
                                                   CONTROL      MG/KG        MG/KG                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Glandular, Mineralization                        5 (10%)      1 (2%)                                                          
      Glandular, Necrosis                                           1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (1)          (1)          (1)                                                 
      Inflammation, Chronic, Multiple                  1 (100%)                                                                     
      Inflammation, Chronic Active, Multiple                        1 (100%)                                                        
      Aorta, Mineralization                                                      1 (100%)                                           
   Heart                                              (50)         (50)         (50)                                                
      Thrombosis                                                    2 (4%)                                                          
      Artery, Mineralization                                        1 (2%)                                                          
      Coronary Artery, Inflammation, Chronic           2 (4%)                                                                       
      Coronary Artery, Media, Hypertrophy              1 (2%)                                                                       
      Endocardium, Inflammation, Chronic Active                                  1 (2%)                                             
      Endocardium, Inflammation, Suppurative                        1 (2%)                                                          
      Myocardium, Angiectasis                          1 (2%)                                                                       
      Myocardium, Fibrosis                             3 (6%)                                                                       
      Myocardium, Inflammation, Chronic                2 (4%)                    1 (2%)                                             
      Myocardium, Inflammation, Chronic Active                      2 (4%)       1 (2%)                                             
      Myocardium, Inflammation, Suppurative            3 (6%)                                                                       
      Myocardium, Mineralization                                                 1 (2%)                                             
      Pericardium, Inflammation, Chronic Active                     1 (2%)                                                          
      Pericardium, Inflammation, Suppurative           1 (2%)                                                                       
      Valve, Inflammation, Suppurative                              1 (2%)                                                          
      Ventricle, Embolus Bacterial                                               1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Gland                                      (50)         (49)         (50)                                                
      Hematopoietic Cell Proliferation                 2 (4%)       2 (4%)                                                          
      Cortex, Cyst                                     1 (2%)                                                                       
      Cortex, Degeneration, Fatty                      4 (8%)       2 (4%)       2 (4%)                                             
      Cortex, Developmental Malformation               1 (2%)       3 (6%)                                                          
      Cortex, Hyperplasia, Focal                       1 (2%)       1 (2%)                                                          
      Cortex, Necrosis                                              1 (2%)       1 (2%)                                             
      Cortex, Vacuolization Cytoplasmic                             1 (2%)                                                          
      Medulla, Angiectasis                                                       1 (2%)                                             
      Medulla, Vacuolization Cytoplasmic               1 (2%)                                                                       
      Spindle Cell, Hyperplasia                       40 (80%)     43 (88%)     48 (96%)                                            
   Islets, Pancreatic                                 (46)         (49)         (49)                                                
      Hyperplasia                                                                7 (14%)                                            
   Parathyroid Gland                                  (46)         (43)         (41)                                                
      Cyst                                             3 (7%)       3 (7%)                                                          
      Ectopic Thymus                                   1 (2%)                                                                       
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    4                                                              
NTP Experiment-Test: 05049-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             DICHLORVOS                                        Date: 09/07/94  
Route: GAVAGE                                                                                                     Time: 05:32:15  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        VEHICLE      20.0         40.0                                                   
                                                   CONTROL      MG/KG        MG/KG                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
   Pituitary Gland                                    (45)         (45)         (44)                                                
      Angiectasis                                      1 (2%)       2 (4%)       6 (14%)                                            
      Pars Distalis, Angiectasis                       2 (4%)                    2 (5%)                                             
      Pars Distalis, Cyst                              1 (2%)                    1 (2%)                                             
      Pars Distalis, Hyperplasia                      13 (29%)     11 (24%)     13 (30%)                                            
      Pars Intermedia, Hyperplasia                                               1 (2%)                                             
   Thyroid Gland                                      (49)         (48)         (50)                                                
      Infiltration Cellular, Lymphocyte                2 (4%)       4 (8%)       2 (4%)                                             
      Inflammation, Chronic Active                                  1 (2%)                                                          
      Inflammation, Suppurative                        1 (2%)       1 (2%)                                                          
      Ultimobranchial Cyst                                          1 (2%)                                                          
      Follicle, Dilatation                             6 (12%)      8 (17%)      8 (16%)                                            
      Follicle, Hyperplasia                                                      1 (2%)                                             
      Follicular Cell, Hyperplasia                     5 (10%)      6 (13%)      6 (12%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   Tissue NOS                                         (7)          (2)                                                              
      Foreign Body                                     6 (86%)      2 (100%)                                                        
      Hemorrhage                                                    1 (50%)                                                         
      Inflammation, Chronic Active                                  1 (50%)                                                         
      Inflammation, Suppurative                        6 (86%)      1 (50%)                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Ovary                                              (46)         (47)         (49)                                                
      Amyloid Deposition                                                         1 (2%)                                             
      Angiectasis                                                                2 (4%)                                             
      Cyst                                            18 (39%)     16 (34%)     19 (39%)                                            
      Hemorrhage                                       3 (7%)       1 (2%)       7 (14%)                                            
      Inflammation, Chronic                            1 (2%)                                                                       
      Inflammation, Chronic Active                                  1 (2%)                                                          
      Inflammation, Suppurative                        7 (15%)      5 (11%)      2 (4%)                                             
      Mineralization                                                1 (2%)                                                          
   Oviduct                                            (1)          (1)                                                              
      Inflammation, Chronic                                         1 (100%)                                                        
   Uterus                                             (50)         (50)         (50)                                                
      Angiectasis                                      1 (2%)                    1 (2%)                                             
      Hemorrhage                                                    1 (2%)                                                          
      Hydrometra                                       1 (2%)       1 (2%)       1 (2%)                                             
      Hyperplasia, Cystic                             40 (80%)     41 (82%)     45 (90%)                                            
      Hyperplasia, Cystic, Multiple                    1 (2%)                                                                       
      Hyperplasia, Glandular                           1 (2%)                    2 (4%)                                             
      Inflammation, Chronic                            2 (4%)                    1 (2%)                                             
      Inflammation, Suppurative                        8 (16%)     13 (26%)      7 (14%)                                            
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    5                                                              
NTP Experiment-Test: 05049-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             DICHLORVOS                                        Date: 09/07/94  
Route: GAVAGE                                                                                                     Time: 05:32:15  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        VEHICLE      20.0         40.0                                                   
                                                   CONTROL      MG/KG        MG/KG                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
GENITAL SYSTEM - CONT                                                                                                               
      Endometrium, Edema                                            1 (2%)                                                          
      Endometrium, Vacuolization Cytoplasmic                                     1 (2%)                                             
      Mucosa, Metaplasia, Squamous                                  1 (2%)       2 (4%)                                             
   Vagina                                             (1)                       (1)                                                 
      Hyperplasia, Squamous                                                      1 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (50)         (50)                                                
      Hyperplasia                                     14 (28%)     10 (20%)      2 (4%)                                             
      Hyperplasia, Reticulum Cell                      1 (2%)                    1 (2%)                                             
      Infiltration Cellular, Mononuclear Cell                       1 (2%)                                                          
      Myelofibrosis                                    1 (2%)                                                                       
   Lymph Node                                         (48)         (49)         (49)                                                
      Bronchial, Inflammation, Suppurative                          1 (2%)                                                          
      Iliac, Hematopoietic Cell Proliferation          1 (2%)                                                                       
      Iliac, Hyperplasia, Lymphoid                     1 (2%)                                                                       
      Iliac, Hyperplasia, Plasma Cell                  1 (2%)       3 (6%)                                                          
      Inguinal, Hyperplasia, Lymphoid                  1 (2%)                                                                       
      Lymphatic, Mandibular, Ectasia                   1 (2%)                                                                       
      Mandibular, Hyperplasia, Histiocytic                          1 (2%)                                                          
      Mandibular, Hyperplasia, Lymphoid                1 (2%)       2 (4%)       4 (8%)                                             
      Mandibular, Hyperplasia, Plasma Cell             3 (6%)       1 (2%)       1 (2%)                                             
      Mandibular, Necrosis, Diffuse                                              1 (2%)                                             
      Mandibular, Pigmentation                                      2 (4%)       3 (6%)                                             
      Mediastinal, Angiectasis                         1 (2%)                                                                       
      Mediastinal, Hematopoietic Cell Proliferation    1 (2%)       1 (2%)                                                          
      Mediastinal, Hemorrhage                                       1 (2%)                                                          
      Mediastinal, Hyperplasia, Histiocytic            1 (2%)       1 (2%)       1 (2%)                                             
      Mediastinal, Hyperplasia, Plasma Cell                         2 (4%)                                                          
      Mediastinal, Inflammation, Suppurative                        1 (2%)                                                          
      Mesenteric, Angiectasis                          1 (2%)                    1 (2%)                                             
      Mesenteric, Atrophy                              1 (2%)                                                                       
      Mesenteric, Hematopoietic Cell Proliferation     3 (6%)       2 (4%)       1 (2%)                                             
      Mesenteric, Hemorrhage                           7 (15%)      5 (10%)      4 (8%)                                             
      Mesenteric, Hyperplasia, Histiocytic             1 (2%)       1 (2%)       2 (4%)                                             
      Mesenteric, Hyperplasia, Lymphoid                2 (4%)       3 (6%)                                                          
      Mesenteric, Hyperplasia, Plasma Cell             1 (2%)       1 (2%)                                                          
      Mesenteric, Infiltration Cellular,                                                                                            
          Polymorphonuclear                            1 (2%)                                                                       
      Mesenteric, Inflammation, Granulomatous          1 (2%)                                                                       
      Mesenteric, Lymphatic, Ectasia                   1 (2%)                                                                       
      Pancreatic, Hyperplasia, Lymphoid                                          2 (4%)                                             
      Pancreatic, Necrosis                                                       1 (2%)                                             
      Renal, Hematopoietic Cell Proliferation          1 (2%)                                                                       
      Renal, Hyperplasia, Lymphoid                     1 (2%)                    2 (4%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    6                                                              
NTP Experiment-Test: 05049-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             DICHLORVOS                                        Date: 09/07/94  
Route: GAVAGE                                                                                                     Time: 05:32:15  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        VEHICLE      20.0         40.0                                                   
                                                   CONTROL      MG/KG        MG/KG                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Renal, Hyperplasia, Plasma Cell                  4 (8%)       1 (2%)       1 (2%)                                             
      Renal, Inflammation, Suppurative                 1 (2%)                                                                       
   Spleen                                             (48)         (49)         (50)                                                
      Fibrosis                                                      1 (2%)                                                          
      Hematopoietic Cell Proliferation Granulocytic    8 (17%)      8 (16%)      2 (4%)                                             
      Hematopoietic Cell Proliferation Erythrocytic    9 (19%)      8 (16%)      7 (14%)                                            
      Hemorrhage                                                    1 (2%)                                                          
      Hyperplasia, Lymphoid                            4 (8%)       4 (8%)       7 (14%)                                            
      Hyperplasia, Megakaryocyte                                    1 (2%)                                                          
      Necrosis                                                      1 (2%)                                                          
      Red Pulp, Pigmentation                                                     1 (2%)                                             
   Thymus                                             (41)         (43)         (45)                                                
      Atrophy                                          2 (5%)       4 (9%)       2 (4%)                                             
      Cyst                                             2 (5%)                    3 (7%)                                             
      Hyperplasia, Lymphoid                            1 (2%)       1 (2%)                                                          
      Mineralization                                                1 (2%)                                                          
      Necrosis, Diffuse                                2 (5%)                                                                       
      Medulla, Hyperplasia, Mononuclear Cell           1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (48)         (48)         (49)                                                
      Hyperplasia, Cystic                             12 (25%)      7 (15%)      9 (18%)                                            
      Hyperplasia, Lobular                             1 (2%)                                                                       
   Skin                                               (50)         (49)         (50)                                                
      Acanthosis                                       1 (2%)       2 (4%)       3 (6%)                                             
      Exudate                                                                    1 (2%)                                             
      Inflammation, Chronic Active                     1 (2%)                                                                       
      Inflammation, Granulomatous                                   1 (2%)                                                          
      Inflammation, Suppurative                                                  1 (2%)                                             
      Ulcer                                            1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (50)         (50)                                                
      Hyperostosis                                    15 (30%)     15 (30%)     14 (28%)                                            
      Necrosis                                         1 (2%)                                                                       
      Cranium, Hyperostosis                            1 (2%)                                                                       
   Skeletal Muscle                                    (4)          (2)          (1)                                                 
      Inflammation, Chronic                            1 (25%)                                                                      
      Inflammation, Chronic Active                                  1 (50%)                                                         
      Mineralization                                                             1 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    7                                                              
NTP Experiment-Test: 05049-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             DICHLORVOS                                        Date: 09/07/94  
Route: GAVAGE                                                                                                     Time: 05:32:15  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        VEHICLE      20.0         40.0                                                   
                                                   CONTROL      MG/KG        MG/KG                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (50)                                                
      Cerebellum, Degeneration, Multifocal                                       1 (2%)                                             
      Cerebellum, Hemorrhage                           1 (2%)       1 (2%)       1 (2%)                                             
      Cerebellum, Infiltration Cellular, Lymphocyte    2 (4%)                                                                       
      Cerebrum, Hemorrhage                             1 (2%)       1 (2%)                                                          
      Cerebrum, Infiltration Cellular, Lymphocyte      1 (2%)                                                                       
      Hippocampus, Necrosis                                                      1 (2%)                                             
      Meninges, Infiltration Cellular, Lymphocyte                                2 (4%)                                             
      Meninges, Infiltration Cellular,                                                                                              
          Polymorphonuclear                                                      1 (2%)                                             
      Thalamus, Degeneration                                                     1 (2%)                                             
      Thalamus, Hemorrhage                             1 (2%)                    1 (2%)                                             
      Thalamus, Infiltration Cellular, Lymphocyte      1 (2%)                                                                       
      Thalamus, Mineralization                        24 (48%)     25 (50%)     18 (36%)                                            
      Vein, Adventitia, Infiltration Cellular,                                                                                      
           Lymphocyte                                  1 (2%)       1 (2%)                                                          
      Ventricle, Hydrocephalus                                                   1 (2%)                                             
      Ventricle, Mineralization                                     1 (2%)                                                          
   Peripheral Nerve                                   (41)         (49)         (45)                                                
      Degeneration                                                  1 (2%)       1 (2%)                                             
      Infiltration Cellular, Plasma Cell                            1 (2%)                                                          
      Infiltration Cellular, Lymphocyte                1 (2%)       1 (2%)       2 (4%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (50)         (50)                                                
      Adenomatosis                                                               1 (2%)                                             
      Bacterium                                                     1 (2%)                                                          
      Hemorrhage                                       1 (2%)                                                                       
      Infiltration Cellular, Histiocyte                2 (4%)       2 (4%)       2 (4%)                                             
      Inflammation, Chronic                           24 (48%)     17 (34%)     19 (38%)                                            
      Inflammation, Suppurative                        2 (4%)       1 (2%)       1 (2%)                                             
      Alveolar Epithelium, Hyperplasia                              1 (2%)                                                          
      Artery, Inflammation, Chronic Active                          1 (2%)                                                          
      Artery, Inflammation, Suppurative                             1 (2%)                                                          
      Artery, Mineralization                                                     1 (2%)                                             
      Interstitium, Edema                              3 (6%)                    2 (4%)                                             
      Pleura, Inflammation, Chronic                                 1 (2%)                                                          
      Pleura, Inflammation, Chronic Active                          1 (2%)                                                          
      Pleura, Inflammation, Suppurative                8 (16%)      2 (4%)                                                          
   Nose                                               (43)         (44)         (47)                                                
      Foreign Body                                     1 (2%)       4 (9%)       2 (4%)                                             
      Fungus                                                        1 (2%)       1 (2%)                                             
      Hemorrhage                                                                 3 (6%)                                             
      Inflammation, Chronic                            4 (9%)       1 (2%)                                                          
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    8                                                              
NTP Experiment-Test: 05049-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             DICHLORVOS                                        Date: 09/07/94  
Route: GAVAGE                                                                                                     Time: 05:32:15  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        VEHICLE      20.0         40.0                                                   
                                                   CONTROL      MG/KG        MG/KG                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
RESPIRATORY SYSTEM - CONT                                                                                                           
      Inflammation, Chronic Active                     3 (7%)                                                                       
      Inflammation, Suppurative                       26 (60%)     29 (66%)     33 (70%)                                            
      Mucosa, Atrophy                                               1 (2%)                                                          
      Mucosa, Necrosis                                              1 (2%)                                                          
      Submucosa, Hyperplasia, Lymphoid                                           2 (4%)                                             
   Trachea                                            (49)         (49)         (49)                                                
      Foreign Body                                     2 (4%)                                                                       
      Glands, Inflammation, Suppurative                1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Ear                                                                          (2)                                                 
      Middle Ear, Inflammation, Suppurative                                      2 (100%)                                           
   Harderian Gland                                    (3)          (3)          (3)                                                 
      Infiltration Cellular, Lymphocyte                1 (33%)                                                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (49)         (50)         (50)                                                
      Casts                                           12 (24%)     10 (20%)      7 (14%)                                            
      Cyst                                             1 (2%)       2 (4%)                                                          
      Glomerulosclerosis                               1 (2%)       2 (4%)                                                          
      Hydronephrosis                                                1 (2%)                                                          
      Infarct                                          1 (2%)       2 (4%)                                                          
      Inflammation, Chronic                           30 (61%)     24 (48%)     26 (52%)                                            
      Inflammation, Suppurative                        1 (2%)       2 (4%)       1 (2%)                                             
      Metaplasia, Osseous                              2 (4%)       3 (6%)       1 (2%)                                             
      Pigmentation                                                  1 (2%)                                                          
      Artery, Inflammation, Chronic                    1 (2%)                                                                       
      Artery, Media, Hypertrophy                       1 (2%)                                                                       
      Glomerulus, Inflammation, Chronic Active                      1 (2%)                                                          
      Renal Tubule, Atrophy                            3 (6%)       1 (2%)       5 (10%)                                            
      Renal Tubule, Degeneration                       1 (2%)                                                                       
      Renal Tubule, Dilatation                         1 (2%)                                                                       
      Renal Tubule, Mineralization                                  2 (4%)                                                          
      Renal Tubule, Regeneration                       8 (16%)      5 (10%)      6 (12%)                                            
   Urinary Bladder                                    (44)         (45)         (49)                                                
      Edema                                            1 (2%)                                                                       
      Inflammation, Chronic                           19 (43%)     13 (29%)     13 (27%)                                            
      Inflammation, Suppurative                        1 (2%)                                                                       
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    9                                                              
NTP Experiment-Test: 05049-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             DICHLORVOS                                        Date: 09/07/94  
Route: GAVAGE                                                                                                     Time: 05:32:15  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          VEHICLE      10.0         20.0                                                   
                                                   CONTROL      MG/KG        MG/KG                                                  
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          50           50           50                                                  
  Early Deaths                                                                                                                      
    Dead                                               9            6            8                                                  
    Moribund                                           5           17           13                                                  
    Accident                                           1                                                                            
  Survivors                                                                                                                         
    Terminal Sacrifice                                35           27           29                                                  
  Animals Examined Microscopically                    50           50           50                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Gallbladder                                        (40)         (35)         (37)                                                
      Amyloid Deposition                                            1 (3%)                                                          
      Concretion                                       2 (5%)                                                                       
      Hemorrhage                                       1 (3%)                                                                       
      Inflammation, Suppurative                        1 (3%)       1 (3%)                                                          
   Intestine Large                                    (49)         (50)         (49)                                                
      Cecum, Hyperplasia, Lymphoid                     2 (4%)                                                                       
      Cecum, Mucosa, Fibrosis                          1 (2%)                                                                       
      Cecum, Serosa, Ectopic Tissue                                              1 (2%)                                             
   Intestine Small                                    (48)         (50)         (49)                                                
      Duodenum, Ulcer                                               1 (2%)                                                          
      Ileum, Peyer's Patch, Hyperplasia, Lymphoid      3 (6%)       2 (4%)       3 (6%)                                             
      Mucosa, Ileum, Dysplasia                         1 (2%)                                                                       
      Serosa, Jejunum, Cyst                                         1 (2%)                                                          
      Serosa, Jejunum, Inflammation, Granulomatous                  1 (2%)                                                          
   Liver                                              (50)         (50)         (50)                                                
      Amyloid Deposition                               1 (2%)                                                                       
      Angiectasis                                                                1 (2%)                                             
      Clear Cell Focus                                 2 (4%)       1 (2%)       2 (4%)                                             
      Eosinophilic Focus                                                         1 (2%)                                             
      Hematopoietic Cell Proliferation                 3 (6%)       3 (6%)       4 (8%)                                             
      Hyperplasia, Focal                                                         1 (2%)                                             
      Inflammation, Chronic                            2 (4%)       3 (6%)       5 (10%)                                            
      Inflammation, Chronic Active                                  1 (2%)                                                          
      Mineralization                                                             1 (2%)                                             
      Bile Duct, Cyst                                               1 (2%)                                                          
      Hepatocyte, Anisokaryosis                        1 (2%)                                                                       
      Hepatocyte, Cytomegaly                           2 (4%)                                                                       
      Hepatocyte, Cytoplasmic Alteration                            2 (4%)                                                          
      Hepatocyte, Karyomegaly                          3 (6%)       2 (4%)       2 (4%)                                             
      Hepatocyte, Necrosis                             3 (6%)       4 (8%)       3 (6%)                                             
      Hepatocyte, Vacuolization Cytoplasmic            7 (14%)      6 (12%)     10 (20%)                                            
      Kupffer Cell, Hyperplasia                        3 (6%)       2 (4%)       1 (2%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   10                                                              
NTP Experiment-Test: 05049-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             DICHLORVOS                                        Date: 09/07/94  
Route: GAVAGE                                                                                                     Time: 05:32:15  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          VEHICLE      10.0         20.0                                                   
                                                   CONTROL      MG/KG        MG/KG                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Kupffer Cell, Pigmentation                       3 (6%)                    1 (2%)                                             
      Vein, Thrombosis                                                           1 (2%)                                             
      Vein, Adventitia, Fibrosis                                                 1 (2%)                                             
   Mesentery                                          (5)          (6)          (8)                                                 
      Fibrosis                                                                   1 (13%)                                            
      Hemorrhage                                                    1 (17%)                                                         
      Inflammation, Suppurative                        1 (20%)                                                                      
      Mineralization                                                1 (17%)      1 (13%)                                            
      Artery, Inflammation, Chronic                                              1 (13%)                                            
      Artery, Necrosis                                              1 (17%)                                                         
      Artery, Thrombosis                                            1 (17%)                                                         
      Fat, Necrosis, Focal                             1 (20%)      3 (50%)      3 (38%)                                            
   Pancreas                                           (50)         (48)         (48)                                                
      Atrophy                                          1 (2%)       1 (2%)                                                          
      Atypia Cellular, Focal                           1 (2%)                                                                       
      Cyst                                                          2 (4%)                                                          
      Hyperplasia, Focal                                            1 (2%)                                                          
      Inflammation, Chronic                            1 (2%)       2 (4%)       2 (4%)                                             
      Inflammation, Suppurative                                     1 (2%)                                                          
      Artery, Inflammation, Chronic                                 1 (2%)                                                          
   Salivary Glands                                    (50)         (50)         (50)                                                
      Inflammation, Chronic                           13 (26%)      8 (16%)      8 (16%)                                            
   Stomach                                            (50)         (50)         (50)                                                
      Forestomach, Cyst                                1 (2%)                                                                       
      Forestomach, Hyperplasia                        10 (20%)      5 (10%)      9 (18%)                                            
      Forestomach, Inflammation, Chronic               3 (6%)       1 (2%)       1 (2%)                                             
      Forestomach, Inflammation, Chronic Active        4 (8%)       2 (4%)       2 (4%)                                             
      Forestomach, Inflammation, Suppurative                        1 (2%)                                                          
      Forestomach, Mineralization                      1 (2%)       1 (2%)                                                          
      Forestomach, Ulcer                               2 (4%)                                                                       
      Forestomach, Mucosa, Hyperplasia                 1 (2%)                                                                       
      Glandular, Cyst                                  1 (2%)                    1 (2%)                                             
      Glandular, Dysplasia                             2 (4%)                                                                       
      Glandular, Erosion                                            2 (4%)                                                          
      Glandular, Inflammation, Chronic Active          1 (2%)                                                                       
      Glandular, Inflammation, Suppurative             3 (6%)       2 (4%)                                                          
      Glandular, Metaplasia, Squamous                  1 (2%)                                                                       
      Glandular, Mineralization                        2 (4%)       3 (6%)       3 (6%)                                             
   Tooth                                              (7)          (10)         (4)                                                 
      Developmental Malformation                       4 (57%)     10 (100%)     3 (75%)                                            
      Foreign Body                                                  1 (10%)                                                         
      Peridontal Tissue, Fibrosis                      1 (14%)                                                                      
      Peridontal Tissue, Inflammation, Chronic                                                                                      
          Active                                       2 (29%)      1 (10%)                                                         
      Peridontal Tissue, Inflammation, Suppurative     1 (14%)      2 (20%)                                                         
      Pulp, Inflammation, Suppurative                               2 (20%)                                                         
____________________________________________________________________________________________________________________________________
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   11                                                              
NTP Experiment-Test: 05049-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             DICHLORVOS                                        Date: 09/07/94  
Route: GAVAGE                                                                                                     Time: 05:32:15  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          VEHICLE      10.0         20.0                                                   
                                                   CONTROL      MG/KG        MG/KG                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (3)                       (1)                                                 
      Inflammation, Chronic Active                     1 (33%)                   1 (100%)                                           
      Aorta, Embolus Bacterial                         2 (67%)                                                                      
      Aorta, Inflammation, Chronic Active              1 (33%)                                                                      
   Heart                                              (50)         (50)         (50)                                                
      Embolus Bacterial                                1 (2%)                                                                       
      Thrombosis                                       1 (2%)                                                                       
      Coronary Artery, Inflammation, Chronic                        2 (4%)       1 (2%)                                             
      Coronary Artery, Inflammation, Chronic Active                              1 (2%)                                             
      Coronary Artery, Inflammation, Suppurative       1 (2%)                                                                       
      Coronary Artery, Necrosis, Fibrinoid             1 (2%)                                                                       
      Endocardium, Inflammation, Chronic               1 (2%)                                                                       
      Epicardium, Fibrosis                             1 (2%)                                                                       
      Epicardium, Inflammation, Chronic                1 (2%)                                                                       
      Myocardium, Fibrosis                             1 (2%)                                                                       
      Myocardium, Inflammation, Chronic                1 (2%)       2 (4%)                                                          
      Myocardium, Inflammation, Suppurative            1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Gland                                      (48)         (50)         (49)                                                
      Developmental Malformation                       1 (2%)       1 (2%)       2 (4%)                                             
      Cortex, Atrophy                                                            1 (2%)                                             
      Cortex, Hyperplasia                              1 (2%)                                                                       
      Cortex, Hyperplasia, Focal                       2 (4%)       4 (8%)       1 (2%)                                             
      Cortex, Infiltration Cellular, Lymphocyte        1 (2%)                                                                       
      Cortex, Vacuolization Cytoplasmic                             2 (4%)                                                          
      Medulla, Hyperplasia                             2 (4%)       1 (2%)       2 (4%)                                             
      Spindle Cell, Hyperplasia                       27 (56%)     27 (54%)     21 (43%)                                            
   Islets, Pancreatic                                 (50)         (47)         (48)                                                
      Dysplasia                                        1 (2%)                                                                       
      Hyperplasia                                     15 (30%)     13 (28%)      7 (15%)                                            
      Infiltration Cellular, Lymphocyte                             1 (2%)                                                          
   Parathyroid Gland                                  (28)         (40)         (43)                                                
      Crystals                                                                   1 (2%)                                             
      Cyst                                                          1 (3%)       2 (5%)                                             
      Infiltration Cellular, Lymphocyte                1 (4%)                    1 (2%)                                             
   Pituitary Gland                                    (40)         (44)         (40)                                                
      Pars Distalis, Cyst                              3 (8%)       4 (9%)                                                          
      Pars Distalis, Hyperplasia                                    2 (5%)       1 (3%)                                             
   Thyroid Gland                                      (45)         (50)         (49)                                                
      Infiltration Cellular, Lymphocyte                1 (2%)                                                                       
      Mineralization                                                             1 (2%)                                             
      Follicle, Crystals                               1 (2%)                                                                       
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   12                                                              
NTP Experiment-Test: 05049-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             DICHLORVOS                                        Date: 09/07/94  
Route: GAVAGE                                                                                                     Time: 05:32:15  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          VEHICLE      10.0         20.0                                                   
                                                   CONTROL      MG/KG        MG/KG                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Follicle, Dilatation                             5 (11%)      3 (6%)       3 (6%)                                             
      Follicular Cell, Hyperplasia                     4 (9%)       3 (6%)       2 (4%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   Tissue NOS                                         (2)          (2)          (1)                                                 
      Foreign Body                                     1 (50%)                                                                      
      Hemorrhage                                       1 (50%)      1 (50%)                                                         
      Inflammation, Suppurative                        1 (50%)                                                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Coagulating Gland                                  (2)                       (1)                                                 
      Dilatation                                       1 (50%)                   1 (100%)                                           
   Epididymis                                         (50)         (49)         (49)                                                
      Fibrosis                                                      1 (2%)                                                          
      Inflammation, Chronic                            1 (2%)                    1 (2%)                                             
      Inflammation, Granulomatous                                   1 (2%)                                                          
   Preputial Gland                                    (20)         (14)         (11)                                                
      Ectasia                                         14 (70%)     12 (86%)      5 (45%)                                            
      Inflammation, Chronic                           10 (50%)      6 (43%)      7 (64%)                                            
      Inflammation, Chronic Active                     1 (5%)                                                                       
      Inflammation, Suppurative                        9 (45%)      3 (21%)      5 (45%)                                            
   Prostate                                           (47)         (49)         (49)                                                
      Dilatation                                                    1 (2%)                                                          
      Inflammation, Chronic                            7 (15%)      4 (8%)       2 (4%)                                             
      Inflammation, Suppurative                        4 (9%)       3 (6%)       1 (2%)                                             
   Seminal Vesicle                                    (5)          (5)          (5)                                                 
      Amyloid Deposition                               1 (20%)                                                                      
      Dilatation                                       1 (20%)                   1 (20%)                                            
      Fibrosis                                         2 (40%)      1 (20%)      2 (40%)                                            
      Inflammation, Chronic                            1 (20%)                   1 (20%)                                            
      Inflammation, Chronic Active                                               1 (20%)                                            
      Inflammation, Suppurative                        2 (40%)      3 (60%)                                                         
      Pigmentation                                                  1 (20%)                                                         
   Testes                                             (50)         (50)         (49)                                                
      Artery, Mineralization                           1 (2%)                                                                       
      Seminiferous Tubule, Atrophy                     3 (6%)       7 (14%)      2 (4%)                                             
      Seminiferous Tubule, Mineralization              4 (8%)       4 (8%)       3 (6%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   13                                                              
NTP Experiment-Test: 05049-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             DICHLORVOS                                        Date: 09/07/94  
Route: GAVAGE                                                                                                     Time: 05:32:15  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          VEHICLE      10.0         20.0                                                   
                                                   CONTROL      MG/KG        MG/KG                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (50)         (50)                                                
      Congestion                                       1 (2%)                                                                       
      Hyperplasia                                      9 (18%)      7 (14%)     10 (20%)                                            
      Hyperplasia, Histiocytic                         1 (2%)                                                                       
      Pigmentation                                     1 (2%)                                                                       
   Lymph Node                                         (47)         (48)         (50)                                                
      Iliac, Hyperplasia, Plasma Cell                  1 (2%)                                                                       
      Inguinal, Fibrosis                               1 (2%)                                                                       
      Inguinal, Hyperplasia, Histiocytic               2 (4%)       1 (2%)       2 (4%)                                             
      Inguinal, Hyperplasia, Plasma Cell                            1 (2%)       2 (4%)                                             
      Inguinal, Infiltration Cellular,                                                                                              
          Polymorphonuclear                                         1 (2%)                                                          
      Inguinal, Pigmentation                                        4 (8%)       4 (8%)                                             
      Lymphatic, Mandibular, Ectasia                                             1 (2%)                                             
      Mandibular, Hyperplasia, Lymphoid                             1 (2%)       1 (2%)                                             
      Mandibular, Hyperplasia, Plasma Cell             1 (2%)       2 (4%)       5 (10%)                                            
      Mandibular, Pigmentation                                      2 (4%)                                                          
      Mesenteric, Angiectasis                                       2 (4%)       1 (2%)                                             
      Mesenteric, Atrophy                              1 (2%)       1 (2%)       1 (2%)                                             
      Mesenteric, Congestion                                                     1 (2%)                                             
      Mesenteric, Hematopoietic Cell Proliferation     4 (9%)       6 (13%)      4 (8%)                                             
      Mesenteric, Hemorrhage                          19 (40%)     14 (29%)     14 (28%)                                            
      Mesenteric, Hyperplasia, Histiocytic             1 (2%)                    1 (2%)                                             
      Mesenteric, Hyperplasia, Lymphoid                1 (2%)                    3 (6%)                                             
      Mesenteric, Hyperplasia, Plasma Cell                          1 (2%)       1 (2%)                                             
      Mesenteric, Infiltration Cellular, Mast Cell                               1 (2%)                                             
      Mesenteric, Infiltration Cellular,                                                                                            
          Megakaryocyte                                                          1 (2%)                                             
      Mesenteric, Infiltration Cellular,                                                                                            
          Polymorphonuclear                                         1 (2%)                                                          
      Mesenteric, Lymphatic, Ectasia                                2 (4%)                                                          
      Renal, Hemorrhage                                             1 (2%)                                                          
      Renal, Hyperplasia, Histiocytic                                            1 (2%)                                             
      Renal, Hyperplasia, Plasma Cell                               1 (2%)                                                          
      Renal, Lymphatic, Ectasia                                     1 (2%)                                                          
   Spleen                                             (49)         (49)         (49)                                                
      Hematopoietic Cell Proliferation Granulocytic    2 (4%)       4 (8%)       5 (10%)                                            
      Hematopoietic Cell Proliferation Erythrocytic   10 (20%)     10 (20%)      9 (18%)                                            
      Hyperplasia, Lymphoid                            2 (4%)       3 (6%)       1 (2%)                                             
      Hyperplasia, Megakaryocyte                                    1 (2%)                                                          
      Hyperplasia, Plasma Cell                                                   1 (2%)                                             
      Necrosis, Focal                                                            1 (2%)                                             
      Lymphoid Follicle, Atrophy                                    1 (2%)                                                          
   Thymus                                             (35)         (32)         (36)                                                
      Atrophy                                                       1 (3%)                                                          
      Cyst                                             3 (9%)       7 (22%)      7 (19%)                                            
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   14                                                              
NTP Experiment-Test: 05049-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             DICHLORVOS                                        Date: 09/07/94  
Route: GAVAGE                                                                                                     Time: 05:32:15  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          VEHICLE      10.0         20.0                                                   
                                                   CONTROL      MG/KG        MG/KG                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Skin                                               (50)         (49)         (50)                                                
      Acanthosis                                      12 (24%)     16 (33%)     17 (34%)                                            
      Acanthosis, Multiple                                          1 (2%)                                                          
      Edema                                                         3 (6%)       1 (2%)                                             
      Erosion                                                                    2 (4%)                                             
      Exudate                                          1 (2%)       1 (2%)       2 (4%)                                             
      Fibrosis                                         3 (6%)       3 (6%)       1 (2%)                                             
      Foreign Body                                                               1 (2%)                                             
      Fungus                                                        1 (2%)       1 (2%)                                             
      Hyperkeratosis                                                             1 (2%)                                             
      Inflammation, Chronic                            4 (8%)       7 (14%)      7 (14%)                                            
      Inflammation, Chronic Active                     1 (2%)       1 (2%)       3 (6%)                                             
      Inflammation, Chronic Active, Multiple           1 (2%)                                                                       
      Inflammation, Granulomatous                                   2 (4%)       2 (4%)                                             
      Inflammation, Suppurative                        1 (2%)       3 (6%)       1 (2%)                                             
      Ulcer                                            1 (2%)       2 (4%)       6 (12%)                                            
      Lymphatic, Angiectasis                                        1 (2%)                                                          
      Sebaceous Gland, Hyperplasia                                               1 (2%)                                             
      Subcutaneous Tissue, Fibrosis                                              1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (50)         (47)                                                
      Dysplasia                                                     2 (4%)                                                          
      Necrosis                                         1 (2%)                    1 (2%)                                             
      Proliferation                                    1 (2%)                                                                       
   Skeletal Muscle                                    (5)          (1)          (4)                                                 
      Foreign Body                                                               1 (25%)                                            
      Hemorrhage                                                                 1 (25%)                                            
      Inflammation, Chronic                            2 (40%)      1 (100%)     1 (25%)                                            
      Inflammation, Chronic Active                     1 (20%)                                                                      
      Inflammation, Granulomatous                                                1 (25%)                                            
      Inflammation, Suppurative                        2 (40%)                   1 (25%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (50)                                                
      Cerebrum, Vacuolization Cytoplasmic                                        1 (2%)                                             
      Hippocampus, Infiltration Cellular,                                                                                           
          Lymphocyte                                                             1 (2%)                                             
      Thalamus, Mineralization                        20 (40%)     26 (52%)     25 (50%)                                            
      Venule, Infiltration Cellular, Lymphocyte        1 (2%)                                                                       
   Peripheral Nerve                                   (40)         (50)         (42)                                                
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   15                                                              
NTP Experiment-Test: 05049-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             DICHLORVOS                                        Date: 09/07/94  
Route: GAVAGE                                                                                                     Time: 05:32:15  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          VEHICLE      10.0         20.0                                                   
                                                   CONTROL      MG/KG        MG/KG                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
NERVOUS SYSTEM - CONT                                                                                                               
      Degeneration                                                  1 (2%)       1 (2%)                                             
      Inflammation, Chronic                            1 (3%)                    2 (5%)                                             
      Inflammation, Subacute                           4 (10%)                   2 (5%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (50)         (50)                                                
      Hemorrhage                                                    1 (2%)       3 (6%)                                             
      Infiltration Cellular, Eosinophil                                          1 (2%)                                             
      Infiltration Cellular, Histiocyte                3 (6%)       8 (16%)      5 (10%)                                            
      Inflammation, Chronic                           27 (54%)     10 (20%)     17 (34%)                                            
      Inflammation, Suppurative                        1 (2%)       2 (4%)       9 (18%)                                            
      Thrombosis                                       1 (2%)                    1 (2%)                                             
      Alveolar Epithelium, Hyperplasia                 1 (2%)       4 (8%)                                                          
      Artery, Mineralization                           1 (2%)                                                                       
      Bronchus, Foreign Body                                                     1 (2%)                                             
      Capillary, Infiltration Cellular,                                                                                             
          Polymorphonuclear                                                      1 (2%)                                             
      Glands, Ectasia                                               1 (2%)                                                          
      Interstitium, Edema                              4 (8%)       4 (8%)       3 (6%)                                             
      Pleura, Inflammation, Suppurative                1 (2%)                                                                       
   Nose                                               (46)         (50)         (48)                                                
      Fungus                                                                     2 (4%)                                             
      Inflammation, Chronic                            1 (2%)                                                                       
      Inflammation, Suppurative                       16 (35%)      5 (10%)     16 (33%)                                            
      Glands, Cyst                                                  1 (2%)                                                          
      Mucosa, Metaplasia, Squamous                                               1 (2%)                                             
   Trachea                                            (49)         (50)         (49)                                                
      Hemorrhage                                                                 1 (2%)                                             
      Submucosa, Cyst                                                            1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                                          (1)                                                 
      Cornea, Hyperplasia                                                        1 (100%)                                           
      Cornea, Inflammation, Chronic Active                                       1 (100%)                                           
   Harderian Gland                                    (6)          (3)          (8)                                                 
      Cyst                                                                       1 (13%)                                            
      Inflammation, Chronic                            1 (17%)                   1 (13%)                                            
   Lacrimal Gland                                     (1)                                                                           
      Inflammation, Chronic                            1 (100%)                                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   16                                                              
NTP Experiment-Test: 05049-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             DICHLORVOS                                        Date: 09/07/94  
Route: GAVAGE                                                                                                     Time: 05:32:15  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          VEHICLE      10.0         20.0                                                   
                                                   CONTROL      MG/KG        MG/KG                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)         (50)                                                
      Amyloid Deposition                               1 (2%)                                                                       
      Bacterium                                        1 (2%)                    1 (2%)                                             
      Calculus Micro Observation Only                  1 (2%)                                                                       
      Casts                                            5 (10%)     11 (22%)      5 (10%)                                            
      Congestion                                                    1 (2%)                                                          
      Cyst                                             3 (6%)       8 (16%)      2 (4%)                                             
      Glomerulosclerosis                                            4 (8%)       3 (6%)                                             
      Hydronephrosis                                                1 (2%)       1 (2%)                                             
      Infarct                                          1 (2%)                    1 (2%)                                             
      Inflammation, Chronic                           29 (58%)     27 (54%)     26 (52%)                                            
      Inflammation, Chronic Active                                  1 (2%)                                                          
      Inflammation, Suppurative                        3 (6%)       2 (4%)       3 (6%)                                             
      Metaplasia, Osseous                              1 (2%)       2 (4%)                                                          
      Cortex, Necrosis                                                           1 (2%)                                             
      Renal Tubule, Atrophy                            2 (4%)       4 (8%)       4 (8%)                                             
      Renal Tubule, Degeneration                       1 (2%)                                                                       
      Renal Tubule, Dilatation                         2 (4%)                                                                       
      Renal Tubule, Mineralization                     2 (4%)       3 (6%)       1 (2%)                                             
      Renal Tubule, Regeneration                      26 (52%)     24 (48%)     22 (44%)                                            
      Renal Tubule, Vacuolization Cytoplasmic          1 (2%)                                                                       
   Urethra                                            (2)                                                                           
      Angiectasis                                      1 (50%)                                                                      
      Inflammation, Chronic Active                     1 (50%)                                                                      
      Inflammation, Suppurative                        1 (50%)                                                                      
   Urinary Bladder                                    (50)         (48)         (49)                                                
      Angiectasis                                      1 (2%)                                                                       
      Calculus Gross Observation                       1 (2%)                                                                       
      Calculus Micro Observation Only                                            2 (4%)                                             
      Edema                                                         1 (2%)                                                          
      Fibrosis                                                                   1 (2%)                                             
      Hemorrhage                                                                 1 (2%)                                             
      Inflammation, Chronic                            4 (8%)       4 (8%)       2 (4%)                                             
      Inflammation, Chronic Active                     1 (2%)       1 (2%)                                                          
      Inflammation, Suppurative                        1 (2%)                    1 (2%)                                             
      Mineralization                                                1 (2%)                                                          
      Mucosa, Hyperplasia                              2 (4%)       1 (2%)                                                          
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   17                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------                                           

--multipart-boundary
Content-type: text/plain
Range: bytes 121506-121506/121506


--multipart-boundary--